Murphy, S. C., Vaughan, A. M., Kublin, J. G., Fishbauger, M., Seilie, A. M., Cruz, K. P., . . . Kappe, S. H. I. (2022). A genetically engineered Plasmodium falciparum parasite vaccine provides protection from controlled human malaria infection. Science translational medicine, 14(659), eabn9709. https://doi.org/10.1126/scitranslmed.abn9709
Chicago Style (17th ed.) CitationMurphy, Sean C., et al. "A Genetically Engineered Plasmodium Falciparum Parasite Vaccine Provides Protection from Controlled Human Malaria Infection." Science Translational Medicine 14, no. 659 (2022): eabn9709. https://doi.org/10.1126/scitranslmed.abn9709.
MLA (9th ed.) CitationMurphy, Sean C., et al. "A Genetically Engineered Plasmodium Falciparum Parasite Vaccine Provides Protection from Controlled Human Malaria Infection." Science Translational Medicine, vol. 14, no. 659, 2022, p. eabn9709, https://doi.org/10.1126/scitranslmed.abn9709.